Literature DB >> 22323539

The impact of a large and frequent deletion in the human TCR β locus on antiviral immunity.

Rebekah M Brennan1, Jan Petersen, Michelle A Neller, John J Miles, Jacqueline M Burrows, Corey Smith, James McCluskey, Rajiv Khanna, Jamie Rossjohn, Scott R Burrows.   

Abstract

The TCR plays a critical role in recognizing intracellular pathogens and initiating pathways leading to the destruction of infected cells by the immune system. Although genetic variability is known to greatly impact on the human immune system and the outcome of infection, the influence of sequence variation leading to the inactivation or deletion of TCR gene segments is unknown. To investigate this issue, we examined the CD8(+) T cell response to an HLA-B7-restricted epitope ((265)RPHERNGFTVL(275)) from the pp65 Ag of human CMV that was highly biased and frequently dominated by a public TCR β-chain encoded by the variable gene segment TRBV4-3. Approximately 40% of humans lack T cells expressing TRBV4-3 because of a 21.5-kb insertion/deletion polymorphism, but these individuals remain responsive to this epitope, using a diverse T cell repertoire characterized by private TCR usage. Although most residues within the bulged 11-mer peptide were accessible for TCR contact, the public and private TCRs showed distinct patterns of sensitivity to amino acid substitution at different positions within the peptide, thereby suggesting that the repertoire diversity generated in the absence of the dominant public TRBV4-3(+) TCR could lead to better protection from viral escape mutation. Thus, variation in the size of the TRBV repertoire clearly contributes toward interindividual variability in immune responses and is presumably maintained in many ethnic groups to enhance the diversity of Ag-specific T cell responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323539     DOI: 10.4049/jimmunol.1102675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire.

Authors:  Ryan O Emerson; William S DeWitt; Marissa Vignali; Jenna Gravley; Joyce K Hu; Edward J Osborne; Cindy Desmarais; Mark Klinger; Christopher S Carlson; John A Hansen; Mark Rieder; Harlan S Robins
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

Review 2.  Donor Unrestricted T Cells: A Shared Human T Cell Response.

Authors:  Ildiko Van Rhijn; D Branch Moody
Journal:  J Immunol       Date:  2015-09-01       Impact factor: 5.422

3.  Specific roles of each TCR hemichain in generating functional chain-centric TCR.

Authors:  Munehide Nakatsugawa; Yuki Yamashita; Toshiki Ochi; Shinya Tanaka; Kenji Chamoto; Tingxi Guo; Marcus O Butler; Naoto Hirano
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

4.  Extended O-GlcNAc on HLA Class-I-Bound Peptides.

Authors:  Fabio Marino; Marshall Bern; Geert P M Mommen; Aneika C Leney; Jacqueline A M van Gaans-van den Brink; Alexandre M J J Bonvin; Christopher Becker; Cécile A C M van Els; Albert J R Heck
Journal:  J Am Chem Soc       Date:  2015-08-19       Impact factor: 15.419

Review 5.  Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors:  K E Applegate; W Rühm; A Wojcik; M Bourguignon; A Brenner; K Hamasaki; T Imai; M Imaizumi; T Imaoka; S Kakinuma; T Kamada; N Nishimura; N Okonogi; K Ozasa; C E Rübe; A Sadakane; R Sakata; Y Shimada; K Yoshida; S Bouffler
Journal:  Radiat Environ Biophys       Date:  2020-03-07       Impact factor: 1.925

6.  T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.

Authors:  Andreas Wieland; Alice O Kamphorst; N Volkan Adsay; Jonathan J Masor; Juan Sarmiento; Tahseen H Nasti; Sam Darko; Daniel C Douek; Yue Xue; Walter J Curran; David H Lawson; Rafi Ahmed
Journal:  Cancer Immunol Immunother       Date:  2018-08-22       Impact factor: 6.968

7.  TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.

Authors:  Suman Paul; Alexander H Pearlman; Jacqueline Douglass; Brian J Mog; Emily Han-Chung Hsiue; Michael S Hwang; Sarah R DiNapoli; Maximilian F Konig; Patrick A Brown; Katharine M Wright; Surojit Sur; Sandra B Gabelli; Yana Li; Gabriel Ghiaur; Drew M Pardoll; Nickolas Papadopoulos; Chetan Bettegowda; Kenneth W Kinzler; Shibin Zhou; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2021-03-01       Impact factor: 17.956

8.  The molecular pathways underlying host resistance and tolerance to pathogens.

Authors:  Elizabeth J Glass
Journal:  Front Genet       Date:  2012-12-14       Impact factor: 4.599

9.  Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis.

Authors:  Swathi R Pullagurla; Małgorzata A Witek; Joshua M Jackson; Maria A M Lindell; Mateusz L Hupert; Irina V Nesterova; Alison E Baird; Steven A Soper
Journal:  Anal Chem       Date:  2014-04-01       Impact factor: 6.986

10.  Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions.

Authors:  Usman Sumo Friend Tambunan; Feimmy Ruth Pratiwi Sipahutar; Arli Aditya Parikesit; Djati Kerami
Journal:  Bioinform Biol Insights       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.